ANS Wins Medical Design Excellence Award for Axxess Product Line
11 April 2005 - 4:01PM
PR Newswire (US)
ANS Wins Medical Design Excellence Award for Axxess Product Line
Neurostimulation Leads Recognized in MDEA Awards for Product Design
and Engineering PLANO, Texas, April 11 /PRNewswire-FirstCall/ --
Advanced Neuromodulation Systems, Inc. (NASDAQ:ANSI) today
announced that its line of Axxess(R) neurostimulation leads,
designed for superior handling and precise placement, has received
a 2005 Medical Design Excellence Award (MDEA). The MDEA competition
is sponsored by Medical Device & Diagnostic Industry
(MD&DI) magazine and organized by Canon Communications LLC, Los
Angeles. "We are honored to be recognized for medical innovation in
the design and engineering of our Axxess leads," said Chris Chavez,
ANS president and CEO. "Axxess leads represent not only advanced
neurostimulation lead technology and design, but a significant leap
forward in specialized miniaturization capabilities and
manufacturing processes. The resulting size and steerability of our
Axxess leads benefit both doctors and their patients." Axxess
neurostimulation leads set a new standard by offering the smallest
diameter available -- 36% thinner than other neurostimulation leads
on the market. The patented unibody design for optimum steerability
is designed to make implantation faster and easier for the
physician and less invasive for the patient. Additionally, the
increased maneuverability allows for greater placement alternatives
to effectively treat chronic pain. Axxess leads are available in
multiple lengths and electrode configurations, providing physicians
options when customizing treatments to the individual needs of the
patient. The leads' low impedance design also helps increase the
longevity of ANS' neurostimulation systems -- Genesis(R),
GenesisXP(TM), GenesisRC(TM), Eon(TM) and Renew(R) spinal cord
stimulation systems. MDEA is the only awards program that
exclusively recognizes contributions to and advances in medical
product design. Award entries are evaluated on the basis of their
design and engineering features, including innovative use of
materials, user-related functions that improve healthcare delivery
and change traditional medical attitudes or practices, features
that provide enhanced patient benefits, and the product development
team's ability to overcome design and engineering challenges so
that the product meets its clinical objectives. The 2005 Medical
Design Excellence Award winners will be honored at a ceremony
during the Medical Design & Manufacturing (MD&M) East
Conference and Exposition, June 13-15, 2005, at New York City's
Jacob K. Javits Convention Center. Gold and silver recipients will
be announced at this time. About Advanced Neuromodulation Systems
(ANS) Advanced Neuromodulation Systems, Inc. designs, develops,
manufactures and markets implantable systems used to manage chronic
intractable pain and other disorders of the central nervous system.
A technology leader in the neuromodulation industry, ANS offers a
family of proprietary neurostimulation devices and implantable drug
pumps for an expanding range of therapeutic applications. ANS was
recently named among FORTUNE's 100 Fastest Growing Companies and
has been recognized among Forbes' 200 Best Small Companies for two
consecutive years. Frost & Sullivan also honored the company
with its Product Innovation Award. Additional information is
available at http://www.ans-medical.com/ . About Medical Design
Excellence Awards The MDEA program is presented by Canon
Communications LLC and supported by the Human Factors and
Ergonomics Society, an interdisciplinary organization of
professionals involved in the human factors field. For more
information about the Medical Design Excellence Awards -- including
additional details about the manufacturers and suppliers that
created the 2005 MDEA-winning products -- visit the MDEA Web site
at http://www.mdeawards.com/ or e-mail: . DATASOURCE: Advanced
Neuromodulation Systems, Inc. CONTACT: Brooke Haneborg of Advanced
Neuromodulation Systems, Inc., +1-972-309-8132, or Web site:
http://www.ans-medical.com/ http://www.mdeawards.com/
Copyright
Advanced Neuromodulation (NASDAQ:ANSI)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Advanced Neuromodulation (NASDAQ:ANSI)
Historical Stock Chart
Von Sep 2023 bis Sep 2024
Echtzeit-Nachrichten über Advanced Neuromodulation Systems (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Advanced Neuromodulation Systems (MM) News-Artikel